SCULLY WILLIAM P purchased $158K of PRTA
SCULLY WILLIAM P purchased 20,000 shares of PROTHENA CORP PUBLIC LTD CO (PRTA) at $7.90 ($0.16M total) on 2026-06-16.
How this was made
The 30-second read
Why it matters
Traders may treat the insider buy as a small sentiment input, but it does not change the company’s fundamentals or near-term outlook on its own.
Market read
New insider-buy disclosure (20,000 shares) provides a modest sentiment datapoint for PRTA.
What to watch
No 10b5-1 plan is cited; without context on prior transactions or total ownership changes, the signal strength is uncertain.
Background
The article is a primary-source SEC Form 4 insider transaction disclosure for Prothena (PRTA).
Ticker impact
Prothena insider William P. Scully (10% owner) filed a Form 4 open-market purchase of 20,000 shares at $7.8995 on 2026-06-16.
Likely limited near-term impact; any effect should be small and fade unless followed by additional disclosures.
The filing is a routine Form 4 transaction with no accompanying guidance, deal, or operational update; insider buys can be informative but are rarely decisive alone.
Market effects
Minimal; this is company-specific insider activity with no sector-wide regulatory/clinical signal.
None indicated.
None indicated.
Counterpoint
The purchase may be discretionary or part of routine liquidity/portfolio management rather than a strong bullish signal.
Key entities
- issuerPROTHENA CORP PUBLIC LTD CO
Subject of the Form 4 insider transaction disclosure.
- insiderSCULLY WILLIAM P
10% owner who purchased 20,000 shares open-market at $7.8995 on 2026-06-16.
